PD-146626

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NamePD-146626
Drug Alias NamePD-146626
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHSV replication inhibitors
TargetsUpdating
Therapy Area/IndicationsHerpes Simplex Virus Type 1 Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesPfizer Global Research and Development
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPfizer Global Research and Development
Active IndicationsN/A
Inactive IndicationsHerpes Simplex Virus Type 1 Infections

Other Information

ATC CodeN/A
Related LinksN/A